Open-label sildenafil treatment of partial and non-responders to double-blind treatment in men with antidepressant-associated sexual dysfunction

International Journal of Impotence Research

Volumn 19, Issue 2, 2007, Pages 167-175

  Nurnberg, H G ^a   Fava, M ^b   Gelenberg, A J ^c   Hensley, P L ^a   Paine, S ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

Author keywords

Antidepressant; Erectile dysfunction; Sexual dysfunction; Sildenafil

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; FLUOXETINE; NORTRIPTYLINE; PAROXETINE; PLACEBO; SERTRALINE; SILDENAFIL; VENLAFAXINE;

ADULT; ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; DRUG SAFETY; DRUG TOLERABILITY; EJACULATION DISORDER; ERECTILE DYSFUNCTION; HAMILTON SCALE; HUMAN; LIBIDO DISORDER; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; OPEN STUDY; PATIENT COMPLIANCE; PATIENT SATISFACTION; PREMATURE EJACULATION; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; REMISSION; RETROGRADE EJACULATION; SCORING SYSTEM; SEXUAL AROUSAL DISORDER; SEXUAL DYSFUNCTION;

ANTIDEPRESSIVE AGENTS; DOUBLE-BLIND METHOD; HUMANS; IMPOTENCE; MALE; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; PURINES; SEROTONIN UPTAKE INHIBITORS; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL; SULFONES; TREATMENT OUTCOME;

EID: 33847406203     PISSN: 09559930     EISSN: 14765489     Source Type: Journal    
DOI: 10.1038/sj.ijir.3901502     Document Type: Article

References (40)

1. Woodwell DA. National Ambulatory Care Medical Survey: 1997. Adv Data 1999; 20: 1-28.
2. Agency for Healthcare Policy Research. Evidence Report on Treatment of Depression - Newer Pharmacotherapies. San Antonio Evidence-Based Practice Center. AHCPR, Evidence-Based Practice Centers: Washington, DC, 1999.
3. American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder. Am J Psychiatry 2000; 157(Suppl): 1-45.
4. Bull SA, Hu XH, Hunkeler EM, Lee JY, Ming EE, Markson LE et al. Discontinuation of use and switching of antidepressants: influence of patient-physician communication. JAMA 2002; 288: 1403-1409.
5. Nurnberg HG. Managing treatment-emergent sexual dysfunction associated with serotonergic antidepressants: before and after sildenafil. J Psychiatr Pract 2001; 7: 92-108.
6. Anderson IM, Nutt DJ, Deakin JF. Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines. British Association for Psychopharmacology. J Psychopharmacol 2000; 14: 3-20.
7. Hu XH, Bull SA, Hunkeler EM, Ming E, Lee JY, Fireman B et al. Incidence and duration of side effects and those rated as bothersome with selective serotonin reuptake inhibitor treatment for depression: patient report versus physician estimate. J Clin Psychiatry 2004; 65: 959-965.
8. Clayton AH, Pradko JF, Croft HA, Montano CB, Leadbetter RA, Bolden-Watson C et al. Prevalence of sexual dysfunction among newer antidepressants. J Clin Psychiatry 2002; 63: 357-366.
9. Zimmerman M, Posternak M, Friedman M, Attiullah N, Baymiller S, Boland R et al. Which factors influence psychiatrists' selection of antidepressants? Am J Psychiatry 2004; 161: 1285-1289.
10. Bloom BS. Daily regimen and compliance with treatment. BMJ 2001; 323: 647.
11. Rudkin L, Taylor MJ, Hawton K. Strategies for managing sexual dysfunction induced by antidepressant medication. Cochrane Database Syst Rev 2004 October 18: CD003382.
12. Nurnberg HG, Hensley PL, Gelenberg AJ, Fava M, Lauriello J, Paine S. Treatment of antidepressant-associated sexual dysfunction with sildenafil: a randomized controlled trial. JAMA 2003; 289: 56-64.
13. Nurnberg HG, Seidman SN, Gelenberg AJ, Fava M, Rosen R, Shabsigh R. Depression, antidepressant therapies, and erectile dysfunction: clinical trials of sildenafil citrate (Viagra®) in treated and untreated patients with depression. Urology 2002; 60(Suppl 2B): 58-66.
14. Fava M, Nurnberg HG, Seidman SN, Holloway W, Nicholas S, Tseng L-J et al. Efficacy and safety of sildenafil in men with serotonergic antidepressant-associated erectile dysfunction: results from a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry 2006; 67: 240-246.
15. Seidman SN, Roose SP, Menza MA, Shabsigh R, Rosen RC. Treatment of erectile dysfunction in men with depressive symptoms: results of a placebo-controlled trial with sildenafil citrate. Am J Psychiatry 2001; 158: 1623-1630.
16. Webster LJ, Michelakis ED, Davis T, Archer SL. Use of sildenafil for safe improvement of erectile function and quality of life in men with New York Heart Association classes II and III congestive heart failure: a prospective, placebo-controlled, double-blind crossover trial. Arch Intern Med 2004; 164: 514-520.
17. Tignol J, Furlan PM, Gomez-Beneyto M, Opsomer R, Schreiber W, Sweeney M et al. Efficacy of sildenafil citrate (Viagra) for the treatment of erectile dysfunction in men in remission from depression. Int Clin Psychopharmacol 2004; 19: 191-199.
18. Nurnberg HG, Gelenberg A, Hargreave TB, Harrison WM, Siegel RL, Smith MD. Efficacy of sildenafil citrate for the treatment of erectile dysfunction in men taking serotonin reuptake inhibitors. Am J Psychiatry 2001; 158: 1926-1928.
19. Brock G, Nehra A, Lipshultz L, Gleave M, Seger M, Padma-Nathan H et al. Influence of vardenafil on erectile dysfunction (ED) and depressive symptoms post radical prostatectomy. Int J Impot Res 2002; 14(Suppl 1): S97-S98.
20. Rosen R, Montorsi F, Assalian P, Rodriguez-Vela L, Porto R, Bangerter K et al. Efficacy and tolerability of vardenafil in men with mild major depressive disorder and erectile dysfunction: the depression related improvement with vardenafil for erectile response (DRIVER) study. Eur Urol (Suppl) 2004; 3: 235.
21. Guy W. ECDEU Assessment Manual for Psychopharmacology. National Institute of Mental Health, US Department of Health, Education, and Welfare: Washington, DC, 1976.
22. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The International Index of Erectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997; 49: 822-830.
23. Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Peña BM. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 1999; 11: 319-326.
24. McGahuey CA, Gelenberg AJ, Laukes CA, Moreno FA, Delgado PL, McKnight KM et al. The Arizona Sexual Experience Scale (ASEX): reliability and validity. J Sex Marital Ther 2000; 26: 25-40.
25. Labbate LA, Lare SB. Sexual dysfunction in male psychiatric outpatients: validity of the Massachusetts General Hospital Sexual Functioning Questionnaire. Psychother Psychosom 2001; 70: 221-225.
26. Nurnberg HG, Gelenberg A, Fava M, Hensley PL, Lauriello J, Paine S. The sexual function inventory: a screening instrument for antidepressant-associated sexual dysfunction. Presented at American Psychiatric Association Annual Meeting; May 7, 2001; New Orleans, LA.
27. Hamilton MA. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56-62.
28. Barsky AJ, Saintfort R, Rogers MP, Borus JF. Nonspecific medication side effects and the nocebo phenomenon. JAMA 2002; 287: 622-627.
29. McCullough AR, Barada JH, Fawzy A, Guay AT, Hatzichristou D. Achieving treatment optimization with sildenafil citrate (Viagra®) in patients with erectile dysfunction. Urology 2002; 60(Suppl 2B): 28-38.
30. Leuchter AF, Cook IA, Witte EA, Morgan M, Abrams M. Changes in brain function of depressed subjects during treatment with placebo. Am J Psychiatry 2002; 159: 122-129.
31. Lydiard RB, Perera P, Batzar E, Clary CM. From the bench to the trench: a comparison of sertraline treatment of major depression in clinical and research patient samples. Prim Care Companion J Clin Psychiatry 1999; 1: 154-162.
32. Balon R. Fluvoxamine-induced erectile dysfunction responding to sildenafil. J Sex Marital Ther 1998; 24: 313-317.
33. Ashton AK, Bennett RG. Sildenafil treatment of serotonin reuptake inhibitor-induced sexual dysfunction. J Clin Psychiatry 1999; 60: 194-195.
34. Schaller JL, Behar D. Sildenafil citrate for SSRI-induced sexual side effects. Am J Psychiatry 1999; 156: 156-157.
35. Gupta S, Droney T, Masand P, Ashton AK. SSRI-induced sexual dysfunction treated with sildenafil. Depress Anxiety 1999; 9: 180-182.
36. Nurnberg H, Lauriello J, Hensley P, Parker L, Keith S. Sildenafil for iatrogenic serotonergic antidepressant medication-induced sexual dysfunction in 4 patients. J Clin Psychiatry 1999; 60: 33-35.
37. Fava M, Rankin MA, Alpert JE, Nierenberg AA, Worthington JJ. An open trial of oral sildenafil in antidepressant-induced sexual dysfunction. Psychother Psychosom 1998; 67: 328-331.
38. Seidman SN, Pesce VC, Roose SP. High-dose sildenafil citrate for selective serotonin reuptake inhibitor-associated ejaculatory delay: open clinical trial. J Clin Psychiatry 2003; 64: 721-725.
39. Segraves RT, Stevenson R, Lee J, Walker D, Wang C, Dickson R. Tadalafil treatment of ED in men on antidepressants. Presented at: Proceedings of the 157th Annual Meeting of the American Psychiatric Association; 2004; New York, NY.
40. Nurnberg HG, Segraves T, Levine S, Frey N, Natanegara F, Wong D et al. Tadalafil is efficacious for treatment of erectile dysfunction in a population of patients with comorbid depression. J Sex Med 2004; 2(Suppl 1): 45.